AK
Ashish Kumar Agrawal
About Ashish Kumar Agrawal
Data last updated:
Ashish Kumar Agrawal is a Director at Nexnos Pharma Limited (since 2023). The company operates in Healthcare. Nexnos Pharma Limited reported revenue of ₹36.91 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 03 May 2023 | 2007 | ₹36.91 Cr (FY 2025) | Active |
Board colleagues of Ashish Kumar Agrawal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kamal Asnani | 01649198 | Nexnos Pharma Limited | Director |
| Rajesh Peswani | 09209394 | Nexnos Pharma Limited | Director |
| Rameshchandra | 09209521 | Nexnos Pharma Limited | Director |
| Vinod Asnani | 01649207 | Nexnos Pharma Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ashish Kumar Agrawal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ashish Kumar Agrawal
Ashish Kumar Agrawal currently holds 1 directorship: Nexnos Pharma Limited (Director, since 03 May 2023, revenue ₹36.91 Cr (FY 2025)).
Ashish Kumar Agrawal was first appointed on 03 May 2023 as Director at Nexnos Pharma Limited.
The current boards of Ashish Kumar Agrawal's companies include Kamal Asnani (Nexnos Pharma Limited), Rajesh Peswani (Nexnos Pharma Limited), Rameshchandra (Nexnos Pharma Limited), Vinod Asnani (Nexnos Pharma Limited).